This 2-hour online course offers a streamlined alternative to traditional 8-hour buprenorphine training, providing a fast and efficient way to equip prescribers with the knowledge needed to effectively treat patients with opioid use disorder.

This 45-minute, on-demand session from the ASAM 2022 Review Course provides an overview of the history of opioid use and opioid regulation, explores the neurobiology and pharmacology of opioids, and reviews treatment options for opioid use disorder and opioid withdrawal.

This 1-hour, on-demand session from the ASAM 53rd Annual Conference describes advantages and barriers to utilizing extended-release buprenorphine rather than sublingual formulations in patients with opioid use disorder.

This 1-hour, on-demand session from the ASAM 53rd Annual Conference provides the knowledge needed to interpret both UDS and confirmatory urine drug testing of opioids.

This 1-hour, on-demand session from the ASAM 53rd Annual Conference discusses the safe and effective use of naloxone in opioid overdose and subsequent management to improve connections to care for opioid use disorder.

This one-hour, on-demand, journal article-based activity presents original research concerning the integration of a community Opioid Treatment Program (OTP) into a Federally Qualified Health Center (FQHC), an approach to expand access to methadone treatment and to promote retention in treatment among patients with opioid use disorder. This study validates this model as a way to increase access to both treatment for OUD and primary care for urban, underserved patient populations.

This one-hour, on-demand, journal article-based activity presents original research on the impact of the opioid intervention court (OIC) as an alternative to traditional treatment courts for people with OUD who are involved with the criminal-legal system and at high risk of overdose. The OICs more rapidly link court participants to treatment in comparison to traditional drug courts. As the time between arrest and post-arraignment drug court entry is one of high risk and may suspend access to treatment for OUD, OICs may demonstrate improved ability to immediately stabilize and reduce overdose risk in court participants.

This 2-hour, on-demand session from the 2024 ASAM State of the Art Course examines new research on AUD treatment, including spironolactone, psychedelics, GLP-1, and technology-assisted approaches.

This 16-hour live course includes 9 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 1-hour and 45-minute, on-demand session from the 2024 ASAM State of the Art Course explores a contextual model of addiction recovery and delve into different tools that may support individuals in maintaining recovery including contingency management, expanded medication access, and culturally attuned interventions.

This 1-hour, 45-minute, on-demand session from the 2024 ASAM State of the Art Course discusses research and treatment approaches for common co-occurring disorders, such as HIV, hepatitis, infectious diseases, and stress and trauma.

This 2-hour, on-demand session from the 2024 ASAM State of the Art Course focuses on the complexities of initiation, exploring the critical phases of initiating and discontinuing addiction treatment and highlighting both established best practices and novel ways of implementing treatment interventions.

This 16-hour, on-demand course is the essential primer for physicians preparing for the addiction medicine examination and also serves to increase other healthcare professionals' knowledge of addiction.

This one-hour, on-demand, journal article-based activity presents a scoping review on the efficacy of GLP-1 agonists in the treatment of patients with substance use disorder. While there is interest in exploring the use of GLP-1 agonists in the treatment of SUD, evidence for safety and efficacy of GLP-1 agonists in humans is limited. The results of this scoping review are mixed, and the authors call for further research to determine the efficacy of GLP-1 agonists in treating SUD.

This one-hour, on-demand, journal article-based activity presents a scoping review on the prevalence of high-potency synthetic opioids (HPSOs) in the nonmedical drug supply and their interactions with medications for opioid use disorder (MOUDs). The interactions between HPSOs and MOUDs are not yet well understood. This review examines the relationship between HPSO exposure and patient outcomes when using common MOUD treatment protocols. It also discusses the implications for clinical practice and suggests directions for future research based on the current research on patient populations impacted by HPSOs.